Literature DB >> 15677438

Localization of mRNA expression of P-glycoprotein at the blood-brain barrier and in the hippocampus.

A M Karssen1, O Meijer, D Pons, E R De Kloet.   

Abstract

The multidrug resistance (mdr) P-glycoprotein is an energy-dependent efflux transporter that protects the brain against a wide variety of neurotoxic compounds. This transmembrane protein is a well-known functional component of the blood-brain barrier and might be present in other brain cells as well. We have developed a riboprobe against the murine mdr1 mRNA recognizing both isoforms of the rodent mdr1 gene to determine the exact localization of P-glycoprotein expression. We have also studied the effects of treatment with a known inducer of P-glycoprotein expression. In situ mRNA hybridization demonstrates that mdr1 mRNA is present in the endothelial cells of brain capillaries throughout the rat brain, indicating that P-glycoprotein is expressed at the endothelial cells forming the blood-brain barrier. Surprisingly, specific mdr1 mRNA expression was also found in neuronal layers of hippocampal fields, particularly in the granule cells of the dentate gyrus. Kainic acid treatment decreased the expression levels of mdr1 mRNA in the dentate gyrus 6 and 24 h after treatment. Our data indicate that P-glycoprotein is expressed by endothelial cells and possibly dentate gyrus neurons The functional role of P-glycoprotein at dentate gyrus neurons is presently unknown.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15677438     DOI: 10.1196/annals.1314.048

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

Review 1.  A users guide to HPA axis research.

Authors:  Robert L Spencer; Terrence Deak
Journal:  Physiol Behav       Date:  2016-11-18

Review 2.  Determinants and significance of corticosterone regulation in the songbird brain.

Authors:  Michelle A Rensel; Barney A Schlinger
Journal:  Gen Comp Endocrinol       Date:  2015-06-30       Impact factor: 2.822

Review 3.  Central regulation of blood pressure by the mineralocorticoid receptor.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 4.  The glucocorticoid receptor: pivot of depression and of antidepressant treatment?

Authors:  Christoph Anacker; Patricia A Zunszain; Livia A Carvalho; Carmine M Pariante
Journal:  Psychoneuroendocrinology       Date:  2011-04       Impact factor: 4.905

Review 5.  Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.

Authors:  Fionn E O'Brien; Timothy G Dinan; Brendan T Griffin; John F Cryan
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 6.  Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?

Authors:  Elise P Gomez-Sanchez
Journal:  Trends Endocrinol Metab       Date:  2011-03-21       Impact factor: 12.015

7.  Estrogen and insulin transport through the blood-brain barrier.

Authors:  Aaron A May; Nicholas D Bedel; Ling Shen; Stephen C Woods; Min Liu
Journal:  Physiol Behav       Date:  2016-05-13

8.  Changes in the brain accumulation of glucocorticoids in abcb1a-deficient CF-1 mice.

Authors:  B L Mason; C M Pariante; S A Thomas
Journal:  J Neuroendocrinol       Date:  2012-11       Impact factor: 3.627

9.  Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.

Authors:  Christoph K Thoeringer; Thomas Wultsch; Anaid Shahbazian; Evelin Painsipp; Peter Holzer
Journal:  Psychoneuroendocrinology       Date:  2007-09-19       Impact factor: 4.905

10.  Functional evidence of multidrug resistance transporters (MDR) in rodent olfactory epithelium.

Authors:  Adrien Molinas; Gilles Sicard; Ingrid Jakob
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.